Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prothrombin | 2 | 2004 | 194 | 0.250 |
Why?
|
| Intracranial Embolism and Thrombosis | 2 | 1996 | 144 | 0.240 |
Why?
|
| Fibrinopeptide A | 1 | 2004 | 43 | 0.240 |
Why?
|
| Cerebrovascular Disorders | 5 | 1998 | 1486 | 0.210 |
Why?
|
| Warfarin | 4 | 2004 | 1493 | 0.200 |
Why?
|
| Thrombin | 1 | 2004 | 600 | 0.190 |
Why?
|
| Carotid Stenosis | 2 | 1997 | 862 | 0.170 |
Why?
|
| Carotid Artery, Internal | 3 | 1997 | 445 | 0.160 |
Why?
|
| Endarterectomy | 1 | 1997 | 196 | 0.140 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 1997 | 279 | 0.130 |
Why?
|
| Peptide Fragments | 2 | 2004 | 5151 | 0.110 |
Why?
|
| Brain Ischemia | 6 | 2004 | 3008 | 0.100 |
Why?
|
| Hyperhomocysteinemia | 2 | 2003 | 118 | 0.100 |
Why?
|
| Homocysteine | 3 | 2003 | 637 | 0.090 |
Why?
|
| Endarterectomy, Carotid | 1 | 1996 | 557 | 0.090 |
Why?
|
| Eye Proteins | 2 | 2004 | 628 | 0.090 |
Why?
|
| Stroke | 4 | 2004 | 9756 | 0.080 |
Why?
|
| Aspirin | 3 | 2004 | 3135 | 0.080 |
Why?
|
| Atrial Fibrillation | 3 | 1993 | 5176 | 0.080 |
Why?
|
| Arteriosclerosis | 2 | 1996 | 1056 | 0.080 |
Why?
|
| Ischemic Attack, Transient | 5 | 1999 | 877 | 0.060 |
Why?
|
| Carotid Artery Diseases | 2 | 1988 | 878 | 0.060 |
Why?
|
| Vitamin B 6 Deficiency | 1 | 2003 | 18 | 0.060 |
Why?
|
| Pyridoxal Phosphate | 1 | 2003 | 123 | 0.060 |
Why?
|
| Intracranial Thrombosis | 1 | 2004 | 108 | 0.050 |
Why?
|
| Membrane Glycoproteins | 2 | 2004 | 3713 | 0.050 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2003 | 27 | 0.050 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2002 | 62 | 0.050 |
Why?
|
| International Normalized Ratio | 1 | 2004 | 382 | 0.050 |
Why?
|
| Attitude to Health | 1 | 1991 | 2025 | 0.050 |
Why?
|
| Brain Infarction | 1 | 2004 | 288 | 0.050 |
Why?
|
| Hemostasis | 2 | 1996 | 468 | 0.050 |
Why?
|
| Subarachnoid Hemorrhage | 4 | 1983 | 1039 | 0.050 |
Why?
|
| Cerebral Arteries | 3 | 1997 | 489 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2004 | 1737 | 0.040 |
Why?
|
| Cerebral Infarction | 1 | 2003 | 975 | 0.040 |
Why?
|
| Mitral Valve Prolapse | 1 | 1999 | 213 | 0.040 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 1998 | 452 | 0.030 |
Why?
|
| Systole | 1 | 1997 | 937 | 0.030 |
Why?
|
| Anticoagulants | 2 | 2004 | 4850 | 0.030 |
Why?
|
| Comorbidity | 3 | 2004 | 10592 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2004 | 3659 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 1996 | 463 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 1997 | 1500 | 0.030 |
Why?
|
| Aquaporins | 2 | 2004 | 176 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 1996 | 1376 | 0.030 |
Why?
|
| Postoperative Period | 1 | 1997 | 1830 | 0.030 |
Why?
|
| Recurrence | 1 | 2004 | 8513 | 0.020 |
Why?
|
| Sheep | 2 | 2004 | 1451 | 0.020 |
Why?
|
| Aortic Diseases | 1 | 1996 | 741 | 0.020 |
Why?
|
| Quality of Life | 1 | 1991 | 13510 | 0.020 |
Why?
|
| Aged | 8 | 2004 | 171786 | 0.020 |
Why?
|
| ROC Curve | 1 | 1996 | 3629 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2004 | 59739 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2004 | 39394 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2004 | 10400 | 0.020 |
Why?
|
| Hemodynamics | 1 | 1997 | 4199 | 0.020 |
Why?
|
| Male | 11 | 2004 | 365203 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 1988 | 449 | 0.020 |
Why?
|
| Humans | 16 | 2004 | 768970 | 0.020 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 1986 | 113 | 0.020 |
Why?
|
| Odds Ratio | 3 | 2003 | 9684 | 0.020 |
Why?
|
| Female | 11 | 2004 | 397515 | 0.020 |
Why?
|
| Dog Diseases | 2 | 1983 | 143 | 0.020 |
Why?
|
| Middle Aged | 8 | 2004 | 223737 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2004 | 41808 | 0.010 |
Why?
|
| Inflammation | 1 | 2003 | 10868 | 0.010 |
Why?
|
| Biopolymers | 1 | 2004 | 183 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 1996 | 3411 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 1998 | 15471 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2004 | 646 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 2004 | 408 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1996 | 2819 | 0.010 |
Why?
|
| Aminophylline | 1 | 1983 | 41 | 0.010 |
Why?
|
| Crystallization | 1 | 2004 | 520 | 0.010 |
Why?
|
| Papaverine | 1 | 1983 | 45 | 0.010 |
Why?
|
| Electroencephalography | 1 | 1998 | 6317 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 2004 | 573 | 0.010 |
Why?
|
| Rupture, Spontaneous | 1 | 1983 | 365 | 0.010 |
Why?
|
| Retinal Artery Occlusion | 1 | 2003 | 83 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 1983 | 575 | 0.010 |
Why?
|
| Lens, Crystalline | 1 | 2004 | 387 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 2004 | 17629 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1996 | 14752 | 0.010 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2002 | 276 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 2560 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1983 | 963 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 1983 | 20776 | 0.010 |
Why?
|
| Cryoelectron Microscopy | 1 | 2004 | 649 | 0.010 |
Why?
|
| Biological Transport | 1 | 2004 | 2085 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 2488 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1991 | 3466 | 0.010 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1983 | 746 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2003 | 1742 | 0.010 |
Why?
|
| Health Status | 1 | 1991 | 4095 | 0.010 |
Why?
|
| Water | 1 | 2004 | 1421 | 0.010 |
Why?
|
| Prospective Studies | 3 | 2002 | 54962 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2004 | 3956 | 0.010 |
Why?
|
| Heterozygote | 1 | 2003 | 2798 | 0.010 |
Why?
|
| Intracranial Aneurysm | 2 | 1983 | 1293 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 1986 | 2660 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1988 | 6002 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2003 | 4124 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2004 | 5404 | 0.010 |
Why?
|
| Prevalence | 2 | 2002 | 15879 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2002 | 22296 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 13427 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2003 | 4179 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 4251 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2003 | 3859 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1986 | 13021 | 0.010 |
Why?
|
| Mitral Valve | 1 | 1999 | 1475 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 12095 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 1991 | 26395 | 0.010 |
Why?
|
| Dogs | 2 | 1983 | 3845 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 2003 | 19023 | 0.000 |
Why?
|
| Adult | 5 | 2003 | 223851 | 0.000 |
Why?
|
| Disease Models, Animal | 2 | 1983 | 18354 | 0.000 |
Why?
|
| Echocardiography | 1 | 1999 | 5047 | 0.000 |
Why?
|
| Age Factors | 1 | 2003 | 18435 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 1992 | 65480 | 0.000 |
Why?
|
| Risk Factors | 1 | 1992 | 74976 | 0.000 |
Why?
|
| Animals | 4 | 2004 | 169335 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2002 | 24333 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 18068 | 0.000 |
Why?
|
| Constriction, Pathologic | 1 | 1983 | 1104 | 0.000 |
Why?
|
| Mutation | 1 | 2003 | 30266 | 0.000 |
Why?
|
| Cerebral Angiography | 1 | 1983 | 1272 | 0.000 |
Why?
|
| Adolescent | 1 | 2003 | 89244 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2002 | 81903 | 0.000 |
Why?
|
| Time Factors | 1 | 1983 | 40261 | 0.000 |
Why?
|
Concepts
(131)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_